A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer

Journal:

ACS Nano

Published:

2026-03-10

DOI:

10.1021/acsnano.5c21831

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
Cancer Institute and Hospital, CAMS & PUMC, China	4.500000	0.25
State Key Laboratory of Molecular Oncology, China	4.500000	0.25
Linyi People's Hospital, China	2.500000	0.14
Shandong Second Medical University, China	2.500000	0.14
Beijing National Laboratory for Molecular Sciences (BNLMS), China	1.000000	0.06
University of Chinese Academy of Sciences (UCAS), China	1.000000	0.06
The University of Sydney (USYD), Australia	1.000000	0.06
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.06

Interested in Pharmacology and Pharmaceutical Sciences?